---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-004922"
form_type: "8-K"
ticker: "UFPT"
cik: "0000914156"
company_name: "UFP TECHNOLOGIES INC"
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:46:49.905328+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# UFP Technologies acquires AQF Medical for €43M; 12.3x EBITDA multiple

## Summary
- Purchase price €43.0M cash; multiple ~12.3x adjusted EBITDA for 12 months ended June 30, 2024.
- AQF Medical is a custom-engineered foam and thermoplastic components manufacturer for medical devices, based in Ireland with JV in Singapore.
- Fourth acquisition by UFP in recent months, expanding European manufacturing and enabling Asian market support.
- CEO R. Jeffrey Bailly highlights shared clients and AQF's leadership team as key to international growth.

## SEC filing metadata
- accession: 0001171843-24-004922
- form_type: 8-K
- ticker: UFPT
- cik: 0000914156
- company_name: UFP TECHNOLOGIES INC
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914156/000117184324004922/0001171843-24-004922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914156/000117184324004922/f8k_082624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-004922
- JSON: https://secwatch.observer/filing/0001171843-24-004922.json
- Plain text: https://secwatch.observer/filing/0001171843-24-004922.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.